Doctor Peter McCartney
Golden Jubilee national hospital, Glasgow (United Kingdom of Great Britain & Northern Ireland)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Dr McCartney graduated from the university of Glasgow with degrees in both Genetics and Medicine. He won a number of awards during his time at university and recently completed a three year Clinical PhD Fellowship appointment within a grant from the Efficacy and Mechanism Evaluation (EME) programme of the UK National Institute for Health Research (Title: A Randomised, Double Blind, Placebo-controlled, Parallel Group Trial of Low-dose Adjunctive alTeplase During prIMary PCI (T-TIME).
Dr McCartney is now completing the remainder of his UK clinical cardiology training in greater Glasgow and Clyde within the subspecialty of interventional cardiology.
His research interests include reperfusion injury and heart failure following acute ST-elevation myocardial infarction (STEMI) and myocardial tissue characterisation post-MI using cardiac magnetic resonance imaging.
Effect of low-dose intracoronary alteplase during primary percutaneous coronary intervention on microvascular obstruction in patients with acute myocardial infarction: a randomized clinical trial.
Event: EuroCMR 2019
Topic: Myocardial Disease
Session: Late-Breaking Science session: the best looks from the Venice Film Festival: trials and population studies
This platform is supported by
